ハンチントン病:世界の治験レビュー(2017年下半期版)

調査会社GlobalData社が発行したリサーチレポート(データ管理コード:GDHC4602CTIDB)
◆英語タイトル:Huntington Disease Global Clinical Trials Review, H2, 2017
◆発行会社/調査会社:GlobalData
◆商品コード:GDHC4602CTIDB
◆発行日:2017年9月22日
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:115
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後24時間以内)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[ハンチントン病:世界の治験レビュー(2017年下半期版)]についてメールでお問い合わせはこちら
当調査レポートでは、世界におけるハンチントン病治療の臨床試験動向について調査・分析し、アジア/ヨーロッパ/アメリカ/中南米の主要国における治験件数、フェーズ別の治験件数、進捗状況別の治験件数、有望なスポンサー、有望な薬剤、治験関連の最新ニュース、主要企業分析、主要な治験プロファイル分析などの情報をご提供致します。
・ハンチントン病:主要地域別治験動向
・ハンチントン病:アジア市場
・ハンチントン病:ヨーロッパ市場
・ハンチントン病:アメリカ市場
・ハンチントン病:中南米市場
・ハンチントン病:中東・アフリカ市場
・ハンチントン病:段階(フェーズ)別治験件数
・ハンチントン病:進捗状況別の治験件数
・ハンチントン病:スポンサーの種類別治験件数
・ハンチントン病:有望なスポンサー
・ハンチントン病:有望な薬剤分析
・ハンチントン病:主要企業分析
*** レポート概要(サマリー)***

Huntington Disease Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Huntington Disease Global Clinical Trials Review, H2, 2017″ provides an overview of Huntington Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Huntington Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

*** レポート目次(コンテンツ)***

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Huntington Disease to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Huntington Disease to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Huntington Disease Therapeutics Clinical Trials 28
Prominent Drugs 30
Latest Clinical Trials News on Huntington Disease 31
Sep 14, 2017: Teva to Present Data for AUSTEDO (deutetrabenazine) Tablets and Other Research at the 2017 Psych Congress 31
Jul 11, 2017: Teva and the Huntington Study Group Announce Publication of Data for AUSTEDO (deutetrabenazine) Tablets in Huntington Disease from ARC-HD Study in JAMA Neurology 31
Clinical Trial Profile Snapshots 33
Appendix 113
Abbreviations 113
Definitions 113
Research Methodology 114
Secondary Research 114
About GlobalData 115
Contact Us 115
Source 115

List of Tables
Huntington Disease Therapeutics, Global, Clinical Trials by Region, 2017* 6
Huntington Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Huntington Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Huntington Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
Huntington Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Huntington Disease Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Huntington Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
Proportion of Huntington Disease to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 14
Huntington Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Huntington Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Huntington Disease to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 17
Huntington Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Huntington Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
Huntington Disease Therapeutics, Global, Clinical Trials by Phase, 2017* 20
Huntington Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
Huntington Disease Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
Huntington Disease Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
Huntington Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
Huntington Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
Huntington Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Huntington Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Huntington Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30

List of Figures
Huntington Disease Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Huntington Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Huntington Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Huntington Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Huntington Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Huntington Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Proportion of Huntington Disease to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 14
Huntington Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Huntington Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Huntington Disease to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 17
Huntington Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Huntington Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
Huntington Disease Therapeutics, Global, Clinical Trials by Phase (%), 2017* 20
Huntington Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 21
Huntington Disease Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
Huntington Disease Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
Huntington Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
Huntington Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 25
Huntington Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
Huntington Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Huntington Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
GlobalData Methodology 114

*** 掲載企業 ***

Pfizer Inc
Teva Pharmaceutical Industries Ltd
Prana Biotechnology Ltd
Neurocrine Biosciences Inc
Siena Biotech SpA
Omeros Corp
Azevan Pharmaceuticals Inc
Amarin Corp Plc
Azidus Brasil
A. Carlsson Research AB

*** レポートのキーワード ***

ハンチントン病、治験、臨床試験、治療薬

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 腫瘍アブレーションの世界市場:技術別(ラジオ波、マイクロ波)、治療別(外科、腹腔鏡、経皮)、用途別、地域別
    The global tumor ablation market size is anticipated to reach USD 2.6 billion by 2027, according to a new report by Grand View Research, Inc. The market is estimated to witness a healthy CAGR of 11.2% during the forecast period. Increasing incidence of cancer and high demand for effective treatment …
  • 世界及び中国のガントリークレーン市場2017
    The 'Global and Chinese Gantry Crane Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Gantry Crane industry with a focus on the Chinese market. The report provides key statistics on the market status of the Gantry Crane manufacturers …
  • 世界及び中国のアニメーション市場2018
    The 'Global and Chinese Animation Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Animation industry with a focus on the Chinese market. The report provides key statistics on the market status of the Animation manufacturers and is a …
  • 生命保険のアジア市場
    Life Insurance in Asia-Pacific Summary Life Insurance in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players includin …
  • 世界主要国における化合物半導体市場2018-2023
    In 2017, the global Compound Semiconductor market size was xx million USD, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. This report studies Compound Semiconductor in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, Ch …
  • 乗用車用エアバッグ布の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Passenger Vehicle Airbag Fabric Revenue, means the sales value of Passenger Vehicle Airbag Fabric This report studies sales (consumption) of Passenger Vehicle Airbag Fabric in Global market, especially in United States, China, Europe and Japan, focuses on top p …
  • エジプトの脊椎手術装置市場見通し
    Egypt Spinal Surgery Market Outlook to 2022 Summary GlobalData’s new report, Egypt Spinal Surgery Market Outlook to 2022, provides key market data on the Egypt Spinal Surgery market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), w …
  • ゴム製コンベヤベルトの世界市場2021-2026:成長・動向・新型コロナの影響・市場予測
    Global Rubber Conveyor Belt Market is expected to register a CAGR of 4.02% over the forecast period (2021 - 2026). The market is witnessing major acquisitions and mergers which is shaping the market landscape. In March 2018, Portfolio company of Incline Equity Partners -- Midwest Industrial Rubber a …
  • 眼球乾燥症候群治療薬の世界市場
    In this report, the global Sicca Syndrome Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, reven …
  • タイロシンの世界市場2021
    Tylosin (CAS 1401-69-0) Market Research Report 2021 aims at providing comprehensive data on Tylosin market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Tylosin description, covers its application areas, manufacturing methods, patents. It captures Tylo …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDHC4602CTIDB )"ハンチントン病:世界の治験レビュー(2017年下半期版)" (英文:Huntington Disease Global Clinical Trials Review, H2, 2017)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。